Document is current
Any future updates will be listed below
-
Authors
Boissel, Nicolas https://orcid.org/0000-0003-2091-7927
Chiaretti, Sabina
Papayannidis, Cristina
Ribera, Josep-Maria https://orcid.org/0000-0003-1042-6024
Bassan, Renato https://orcid.org/0000-0001-8214-2894
Sokolov, Andrey N. https://orcid.org/0000-0003-1494-7978
Alam, Naufil
Brescianini, Alessandra
Pezzani, Isabella
Kreuzbauer, Georg
Zugmaier, Gerhard https://orcid.org/0000-0001-6879-2671
Foà, Robin
Rambaldi, Alessandro
-
Funding
Funding for this research was provided by:
Amgen (Europe) GmbH
- License Information
-
More Information
Article History
Received: 5 August 2022
Revised: 1 December 2022
Accepted: 2 December 2022
First Online: 4 January 2023
Competing interests
: Nicolas Boissel received honoraria from Amgen, Ariad, Jazz, Pfizer, Servier, and Shire. Sabina Chiaretti received honoraria for advisory boards from Amgen Inc., Incyte, Pfizer, and Shire. Cristina Papayannidis received honoraria from Amgen, Novartis, Pfizer, Shire, and Teva Pharmaceuticals for travel, sponsored lectures, and advisory board meetings. Josep-Maria Ribera received research funds and honoraria from, and served on advisory boards for, Amgen, Incyte, Novartis, Pfizer, and Shire. Renato Bassan received honoraria for advisory boards from Amgen Inc., Incyte, Pfizer, and Shire. Andrey N. Sokolov received support from Amgen, Astellas, Novartis, and Pfizer for travel and sponsored lectures. Naufil Alam and Georg Kreuzbauer were employees of Amgen at the time of this work and still hold stocks of Amgen Inc. Alessandra Brescianini and Isabella Pezzani are employees and stockholders of Amgen. Gerhard Zugmaier is employed by Amgen Research (Munich) GmbH, owns stock in Amgen Inc., and holds patents relating to blinatumomab. Robin Foà received honoraria for speaker bureau and advisory boards for Amgen Inc., Incyte, Janssen, Novartis, and Pfizer. Alessandro Rambaldi received support from Amgen, Celgene, Novartis, and Pfizer for travel, sponsored lectures, and advisory board meetings.
